Page last updated: 2024-10-18

glycine and Hyperactivity, Motor

glycine has been researched along with Hyperactivity, Motor in 13 studies

Research Excerpts

ExcerptRelevanceReference
" They were challenged on the eighth day with one dosage and sacrificed 3 h later."1.32Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons. ( Li, LT; Lin, WW; Yin, HS; Yu, MF, 2003)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedersen, L2
Parlar, S2
Kvist, K1
Whiteley, P2
Shattock, P2
Longo, F1
Russo, I1
Shimshek, DR1
Greggio, E1
Morari, M1
Haracopos, D1
Knivsberg, AM1
Reichelt, KL1
Jacobsen, J1
Seim, A1
Schondel, M1
Ballard, TM1
Pauly-Evers, M1
Higgins, GA1
Ouagazzal, AM1
Mutel, V1
Borroni, E1
Kemp, JA1
Bluethmann, H1
Kew, JN1
Yu, MF1
Lin, WW1
Li, LT1
Yin, HS1
Shin, KW1
Hong, JT1
Yoo, HS1
Song, S1
Oh, KW1
Miranda-Contreras, L1
Dávila-Ovalles, R1
Benítez-Díaz, P1
Peña-Contreras, Z1
Palacios-Prü, E1
Costa, MJ1
Monteiro, DA1
Oliveira-Neto, AL1
Rantin, FT1
Kalinin, AL1
Kato, K1
Shishido, T1
Ono, M1
Shishido, K1
Kobayashi, M1
Niwa, S1
Darracq, L1
Drouin, C1
Blanc, G1
Glowinski, J1
Tassin, JP1
Ma, J1
Leung, LS1
Toth, E1
Lajtha, A1
Stern, P1
Catović, S1
Stern, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A1 Beta Casein Free Milk (a2 Milk) for Autism and Attention-deficit Hyperactivity Disorder[NCT02911194]40 participants (Actual)Interventional2016-09-30Completed
The ScanBrit Randomised Controlled Study of Gluten- and Casein-free Dietary Intervention for Children With Autism Spectrum Disorders[NCT00614198]Phase 272 participants (Actual)Interventional2006-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.

ADOS (Autism Diagnostic Observation Schedule): module 1 cutoff scores (communication+social): autism=12, autism spectrum (AS)=7; module 2 cutoffs: autism=12, AS=8; module 3 cutoffs: autism=10; AS=7. GARS (Gilliam Autism Rating Scale): <80 low probability of autism, 81-90 below average, 91-110 average, >110 above average probability of autism. VABS (Vineland Adaptive Behaviour Scale): <69 (low ability), 70-84 (moderate/low), 85-115 (adequate), 116-130 (moderate/high), >130 (high). ADHD-IV: 0=no problems indicated. >11 attention & >11 hyperactivity = ADHD diagnosis. (NCT00614198)
Timeframe: Baseline - 8 months - 12 months - 24 months

,
InterventionUnits on a scale (Mean)
ADOS - Communication (8 months)ADOS - Communication (24 months)ADOS - Social (8 months)ADOS - Social (24 months)ADOS - Repetitive behaviours (8 months)ADOS - Reptitive behaviours (24 months)GARS - Social (8 months)GARS - Social (12 months)GARS - Social (24 months)GARS - Communication (8 months)GARS - Communication (12 months)GARS - Communication (24 months)GARS - Stereotyped behaviours (8 months)GARS - Stereotyped behaviours (12 months)GARS - Stereotyped behaviours (24 months)VABS - Communication (8 months)VABS - Communication (12 months)VABS - Communication (24 months)VABS - Social (8 months)VABS - Social (12 months)VABS - Social (24 months)VABS - Daily Living (8 months)VABS - Daily Living (12 months)VABS - Daily Living (24 months)ADHD-IV - Inattention (8 months)ADHD-IV - Inattention (12 months)ADHD-IV - Inattention (24 months)ADHD-IV - Hyperactivity (8 months)ADHD-IV - Hyperactivity (12 months)ADHD-IV Hyperactivity (24 months)
Gluten- and Casein-free Dietary Intervention-0.16715-0.161760.016807-0.5042-0.14706-0.14216-1.07692-1.57692-1.88235-1.23077-1.47826-2-0.96154-1.46154-0.882350.230770.923081.277781.53846-4.153850.722223.038463.46154-0.16667-2.15385-2.19231-2.29412-2.03846-1.69231-2.58824
No Gluten- and Casein-free Dietary Intervention0.082350.185290.025210.025210.03431-0.0049-0.06897-0.42308-1.11765-0.51724-1.46154-1.29412-0.7931-1.3333-1.705881.251.85714-2.058820.92857-3.25-3.29412-1.64286-2.85714-4.647060.31034-0.03704-3.35294-0.17241-0.92593-4.17647

Trials

2 trials available for glycine and Hyperactivity, Motor

ArticleYear
Data mining the ScanBrit study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders: behavioural and psychometric measures of dietary response.
    Nutritional neuroscience, 2014, Volume: 17, Issue:5

    Topics: Attention; Caseins; Child; Child Development Disorders, Pervasive; Child, Preschool; Data Mining; Di

2014
The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.
    Nutritional neuroscience, 2010, Volume: 13, Issue:2

    Topics: Aging; Attention; Caseins; Child; Child Development; Child Development Disorders, Pervasive; Child,

2010
The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.
    Nutritional neuroscience, 2010, Volume: 13, Issue:2

    Topics: Aging; Attention; Caseins; Child; Child Development; Child Development Disorders, Pervasive; Child,

2010
The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.
    Nutritional neuroscience, 2010, Volume: 13, Issue:2

    Topics: Aging; Attention; Caseins; Child; Child Development; Child Development Disorders, Pervasive; Child,

2010
The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders.
    Nutritional neuroscience, 2010, Volume: 13, Issue:2

    Topics: Aging; Attention; Caseins; Child; Child Development; Child Development Disorders, Pervasive; Child,

2010

Other Studies

11 other studies available for glycine and Hyperactivity, Motor

ArticleYear
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.
    Neurobiology of disease, 2014, Volume: 71

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aging; Analysis of Variance; Animals; Brain; Dose-Res

2014
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Aug-01, Volume: 22, Issue:15

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Binding, Competitive; Biogenic Amine

2002
Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons.
    Synapse (New York, N.Y.), 2003, Dec-15, Volume: 50, Issue:4

    Topics: Age Factors; Amphetamine; Animals; Animals, Newborn; Behavior, Animal; Brain; Cells, Cultured; Centr

2003
Inhibitory effects of glycine on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity in mice.
    Archives of pharmacal research, 2003, Volume: 26, Issue:12

    Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Glycine; Hyperkinesis; Male; Mice; Mice,

2003
Effects of prenatal paraquat and mancozeb exposure on amino acid synaptic transmission in developing mouse cerebellar cortex.
    Brain research. Developmental brain research, 2005, Nov-07, Volume: 160, Issue:1

    Topics: Animals; Aspartic Acid; Cerebellar Cortex; Disease Models, Animal; Down-Regulation; Female; Fungicid

2005
Oxidative stress biomarkers and heart function in bullfrog tadpoles exposed to Roundup Original.
    Ecotoxicology (London, England), 2008, Volume: 17, Issue:3

    Topics: Animals; Catalase; Glycine; Glyphosate; Herbicides; Hyperkinesis; Larva; Liver; Myocardial Contracti

2008
Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:3

    Topics: Animals; Disease Models, Animal; Glycine; Hippocampus; Hyperkinesis; Ibotenic Acid; Methamphetamine;

2001
Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the D-amphetamine-induced release of functional dopamine.
    Neuroscience, 2001, Volume: 103, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Benz

2001
Metabotropic glutamate receptors in the hippocampus and nucleus accumbens are involved in generating seizure-induced hippocampal gamma waves and behavioral hyperactivity.
    Behavioural brain research, 2002, Jun-15, Volume: 133, Issue:1

    Topics: Animals; Behavior, Animal; Benzoates; Electroencephalography; Electrophysiology; Excitatory Amino Ac

2002
Antagonism of phencyclidine-induced hyperactivity by glycine in mice.
    Neurochemical research, 1986, Volume: 11, Issue:3

    Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Glycine; Hyperkinesis; Locomotion; Male;

1986
Mechanism of action of substance P.
    Naunyn-Schmiedeberg's archives of pharmacology, 1974, Volume: 281, Issue:2

    Topics: Animals; Brain Chemistry; Diethylamines; Glycine; Humans; Hyperkinesis; Male; Mice; Nitriles; Spinal

1974